S1PR2 and cancer: The immunoexpression of anti-caspase 3 showed lower apoptotic cells in the tumor region compared to healthy surrounding regions of both S1PR2+/+ and S1PR2−/− mice, indicating an enhanced survival of cancer cells (Fig. S3).